World-first, so what’s next? How you can join the revolution for Change!

Don’t miss out - Get your tickets early!

Join this FREE WEBINAR presented by Dr Eli Kotler, Dr Michael Winlo, Dr Lauren MacDonald (UK), Tania de Jong AM, Peter Hunt AM and Scott Edwards and more speakers to be announced.

Topic: Psychedelic Therapies in Australia: Achievements, Challenges and Opportunities

Join us for a live webinar on Psychedelic Therapies in Australia: Achievements, Challenges, and Opportunities. Explore the current legal landscape and hear from leading psychiatrists pioneering treatments. You'll also learn about Mind Medicine Australia's current focus including our Certificate in Psychedelic-Assisted Therapies (CPAT) and Patient Support Fund.

What’s legal right now? How is it progressing?
Hear from psychiatrists who are treating patients with these therapies
What is MMA’s current focus?
Learn more about our world-leading Certificate in Psychedelic-Assisted Therapies (CPAT), our Patient Support Fund and health insurance options
Hear from some CPAT Graduates who are already practising about what they have learnt
What are some of the opportunities, challenges and wishes for the future
How you can be part of the change now

EVENT DETAILS

DATE: 13th May 2024
TIME: 6:55pm (AEST) for 7:00pm start, finishing at 8:15pm
DURATION: 75 minutes (incl Q&A)
LOCATION: Online - a link will be emailed to you with the viewing details

ABOUT THE PRESENTERS

More to be announced soon.

Dr Eli Kotler
Psychiatrist, Psychotherapist

Dr Eli Kotler is a Consultant Psychiatrist and Psychodynamic Psychotherapist. He is the Medical Director of Malvern Private Hospital, an addiction and trauma hospital in Melbourne. Eli completed the inaugural Mind Medicine Australia Certificate in Psychedelic-Assisted Therapies (CPAT) course, and has since been on its faculty, currently serving as CPAT’s Australian Course Director.

As a psychiatric trainee, Eli was awarded the Royal College of Psychiatrists Trainee Prize for his Scholarly Project on Depression, as well as a Research Committee Trainee award for his work on Philosophy of Mind. As an adjunct lecturer at Monash University, he oversees medical students on their addiction medicine rotation. He has been invited as a keynote speaker to several conferences and meetings to discuss addictions, trauma and psychedelics.

Eli sits on the Committee of the ANZMHA to help organise their yearly addiction conference. He also sits on the inaugural Clinical Advisory Group for the Victorian Responsible Gambling Foundation. Eli is an Associate Fellow of the Royal Australasian College of Medical Administrators, and is a member of the Australasian Professional Society on Alcohol and other Drugs. He also has extensive research experience with novel therapeutics for neurodegenerative diseases.

Due to his interest in trauma, Eli has been appointed an Independent Medical Examiner by WorkSafe Victoria. He has been appointed by the Minister for Workplace Safety to sit on the Victorian Medical Panels, and is an expert witness in historical abuse cases.

Clinically, Eli works in a psychodynamic framework, and attempts to help his patients find freedom from their addictions and trauma through relational experiences, and experiential self-awareness. He is part of the AFL Player's Association referral network for addiction issues, and his interests in depth-psychology and neuroscience led him to found the Melbourne Neuropsychoanalytic Group. Eli is a Board Director of Mind Medicine Australia.

Dr Michael Winlo

Chief Executive Officer and Managing Director, Emyria

Dr Michael Winlo, chief executive of Emerald Clinics since August 2019, was chief executive of Linear Clinical Research for 3 years and remained on the board from July 2019 when he stepped down from the CEO role to lead a startup company in digital health innovation. Linear Clinical Research is the clinical trials arm of the Harry Perkins Institute of Medical Research. Dr Winlo holds a Bachelor of Medicine and Surgery from the University of Western Australia, and an MBA from the Stanford Graduate School of Business. He was a co-founder of medical device startup Cerulean Medical in 2007, and spent five years in the US growing the health practice of data analysis firm Palantir Technologies.

Dr Lauren Macdonald (UK)

Psychedelic Clinical Trial Doctor, Retreat Facilitator and co-founder of Essence Medicine

Lauren Macdonald is a psychiatry doctor, psychedelic therapy guide and group facilitator. For the last few years she has been a clinical trial doctor at The Centre for Psychedelic Research (Imperial College London) investigating psilocybin-assisted therapy for anorexia-nervosa, chronic pain, and treatment-resistant depression.

Alongside her clinical roles Lauren regularly facilitates psilocybin retreats in The Netherlands, and is co-founder of Essence Medicine, an organisation providing psycho-spiritual group support to people facing life threatening illness. Lauren is also passionate about educating future psychedelic facilitators and delivers integrative, experiential and heart-centred training for Mind Medicine (Australia) and PsyEdu (UK).

Lauren has trained in medicine, psychology, MDMA-assisted therapy, and yoga, and continues to be a student of earth-based, indigenous wisdom traditions. She is driven to help people come home to themselves, unfold more of who they truly are, and deepen into the beauty and mystery of life.

Tania de Jong AM
Founder & Executive Director of Mind Medicine Australia

Tania de Jong AM is a trail-blazing Australian soprano, award-winning social entrepreneur, creative innovation catalyst, spiritual journey woman, storyteller and global speaker. Tania is one of Australia’s most successful female entrepreneurs and innovators developing 5 businesses and 4 charities over the past 3 decades. She is Founder and Executive Producer of future-shaping events series, Creative Innovation Global. She was appointed a Member of the Order of Australia in June 2008 and named one of the 100 Women of Influence and the 100 Australian Most Influential Entrepreneurs in 2018.

Peter Hunt AM
Founder & Chair of Mind Medicine Australia

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years. He co-founded and was Executive Chairman of one of Australia’s leading investment banking advisory firms, Caliburn Partnership (now called Greenhill Australia) and continued as Chairman of the Firm after its sale to Greenhill Inc in 2009. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world. He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He founded Women’s Community Shelter in 2011 and remains on the Board. He was previously Chairman of So They Can, Grameen Australia and Grameen Australia Philippines. Peter is a Director of Project Rozana and an Advisory Board member of the Monash Sustainable Development Institute. Peter also acts as a pro bono adviser to Creativity Australia.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Scott Edwards

Executive Officer at Mind Medicine Australia

Scott has had a diverse career, working across a variety of fields. After originally training and working as a professional musician, he founded and bootstrapped a successful online music education company called Ear Training HQ at age 23. Ear Training HQ taught an innovative approach to skill development that he developed. He successfully taught this to thousands of students over 10 years. He has committed much of the last 10 years to introspective practice, with a central focus on Buddhist teachings. During this time he has trained and worked as a bodyworker, somatic therapist and meditation teacher.

Through his introspective practice and his somatic work, he has developed a deep interest in psychedelic and other altered state based therapies and the connection between these therapeutic approaches and the introspective process. Through the emergence of psychedelic-assisted therapy, he sees an opportunity for a deeper understanding of introspective practice emerge in our culture, with the potential to support greater happiness and wellbeing for all.

---

MEDICINAL PSYCHEDELIC TREATMENTS

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

SUPPORT PSYCHEDELIC RESEARCH AND THERAPY DEVELOPMENT

Your donation to Mind Medicine Australia will help us accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support. Please click here to make a tax-deductible donation.

DISCLAIMER

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms i.e. Facebook, Instagram or zoom private and public chat forms during the webinar. Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters. Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.